Biodesix, Inc.

NASDAQ:BDSX

Medical - Diagnostics & Research

Healthcare
$8.40 +13.40%

+$2.04 today

Market cap
$68.38M
Beta
0.59
P/E (TTM)
-5.2
EPS (TTM)
-$3.31
52W Low $5.00High $20.21

Volume 0.17M

Average 0.06M

BDSX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Biodesix, Inc.NASDAQ: BDSX

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 9.66M shares rose 31.8% year over year, ahead of the +14.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 19.7% from the prior quarter. Over 3 fiscal years it compounded at +53.1% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +31.8% holds above the trailing-twelve-month pace of +14.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
9.66M+19.7% QoQ
Last fiscal yearDec 2025
7.55M+16.5% YoY
LTMMar 2026
8.14M+14.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+31.8%——
1 year+16.5%——
3-year CAGR+53.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
7.55M USD
Year-over-year change
+16.5%
4-year CAGR
+53.3%

Weighted Avg Shares (Diluted) vs competitors

How BDSX compares with its peers on the latest reported figures

  • BDSX's LTM Mar 2026 weighted avg shares (diluted) of 8.14M shares is the lowest of the 5 companies compared; the peer median is 37.21M shares.
  • Its year-over-year change of +14.9% is the 4th highest of 5, against a peer median of +25.8%.
  • Over three fiscal years its annual growth of +53.1% compares with a peer median of +15.8%.
BDSX Competitors Peer median
Weighted Avg Shares (Diluted) for BDSX and competitors
Company Period LTM YoY 3-year CAGR
XLOXilio Therapeutics, Inc.LTM Mar 202665.27M +1380.9%+249.6%
PDSBPDS Biotechnology CorporationLTM Mar 202648.66M +29.4%+17.5%
INMBINmune Bio, Inc.LTM Mar 202625.76M +22.3%+14.0%
OKUROnKure Therapeutics, Inc.LTM Mar 202613.55M +1.4%+0.4%
BDSXBiodesix, Inc.LTM Mar 20268.14M +14.9%+53.1%
Peer median (excluding BDSX) 37.21M+25.8%+15.8%

Competitors are the stored peer set for BDSX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue54.51M38.21M49.09M71.32M88.5M
Cost of Revenue30.52M14.15M13.01M15.57M16.72M
Gross Profit23.99M24.06M36.08M55.75M71.78M
Gross Margin44.0%63.0%73.5%78.2%81.1%
Research & Development12.79M13.1M9.99M9.56M12M
Selling, General & Admin50.52M61.46M67.39M80.45M87.55M
Operating Expenses64.93M74.65M77.42M90.25M99.55M
Depreciation & Amortization3.18M5.84M5.51M5.46M5.6M
EBITDA(35.47M)(51.53M)(37.1M)(29.22M)(21.95M)
EBITDA Margin-65.1%-134.9%-75.6%-41.0%-24.8%
Operating Income(40.94M)(50.59M)(41.34M)(34.5M)(27.77M)
Operating Margin-75.1%-132.4%-84.2%-48.4%-31.4%
Interest Income00000
Interest Expense4.51M8.07M9.54M8.26M7.72M
Other Income / Expenses(2.22M)(14.86M)(10.8M)(8.43M)(7.5M)
Income Before Tax(43.16M)(65.45M)(52.15M)(42.93M)(35.27M)
Pre-Tax Margin-79.2%-171.3%-106.2%-60.2%-39.8%
Income Tax Expense00000
Net Income(43.16M)(65.45M)(52.15M)(42.93M)(35.27M)
Net Margin-79.2%-171.3%-106.2%-60.2%-39.8%
EPS (Basic)(31.60)(31.00)(12.80)(6.60)(4.67)
EPS (Diluted)(31.60)(31.00)(12.80)(6.60)(4.67)
Weighted Avg Shares1.37M2.11M4.11M6.48M7.55M
Weighted Avg Shares (Diluted)1.37M2.11M4.11M6.48M7.55M

Biodesix, Inc.

NASDAQ:BDSX

Intrinsic Alpha fair value

Locked

Current Price

$8.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.